Robichaud Albert 4
4 · Sage Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2021-06-15$58.80/sh−1,144$67,267→ 139,651 total - Award
Common Stock
2021-06-15+4,000→ 140,795 total
Footnotes (2)
- [F1]On March 25, 2020, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 10,000 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on June 15, 2021, resulting in the vesting of the PSU as to 4,000 shares.
- [F2]Reflects beneficial ownership balance, which includes 54 shares purchased on December 31, 2019 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan (the "ESPP") and 341 shares purchased on June 30, 2020 under the ESPP.